June 17, 2026

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN protein loss is associated...

recent articles

30 UCLA Sub-Specialty Pathologists Available to Second Affiliated Hospital Zhejiang University Vista, CA – April 26, 2011 - Aperio, the global leader in providing digital pathology solutions that improve patient care, today announced...

Join us for the 2011 “Discover Your Path to Improved Patient Care” Regional Healthcare Event Series featuring Jared N. Schwartz, M.D., Ph.D.,  Aperio technical experts, and leading innovators who will discuss how they...

Pharmaceutical veteran anatomic pathologist strengthens Flagship's expertise in oncology and clinical trials Flagstaff, AZ (04/26/2011) —Flagship Biosciences announced today that Dr. David Eberhard MD, PhD has been appointed Chief...

This sounds interesting -- combination of high-end imaging system from Philips with added quantitation tools provided by NEC.  According to the press release, look for results of this partnership by years' end. Eindhoven, the...

In case you missed it -- Pat Foley call for Game 6 Blackhawks vs. Canucks.  No better announcer in hockey.  Best thing I have heard all year -- "Game 7 will be played on Tuesday...

On April 7, 2011, the Centers for Medicare & Medicaid Services ("CMS") issued its proposed regulations covering Accountable Care Organizations ("ACOs"). When adopted in final form, this rule will implement Section 3022...

OR

platinum partners

gold partners

Silver Partners

Media Partners